Baird Melissa's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Jun 7, 2023
- Accession no.
- 0001773751-23-000157
- Filed
- Jun 7, 2023
- Trade date
- May 19-Jun 5, 2023
- Filing delay
- 19 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $81.2K. It was filed 19 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baird MelissaCIK 0001837815 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2023 | Class A Common Stock | SSaleDisposed | −9,133 | $8.89F2 | −$81,192.37 | 426,412 | Direct | |
| May 19, 2023 | Class A Common Stock | JOtherAcquired | +2,500 | $3.00 | +$7,500 | 428,912 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.79 - $8.985. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.